Green Cross has targeted the Latin America with its blood fractionation product when its final goal is the U.S.

Green Cross (CEO Eun-cheol Huh) announced on the 4^th that the company won an order to supply Immunoglobulin IV Globulin S (IVIG-SN) worth of $ 5.72 million on the recent Brazilian governmental pharmaceutical bidding.

The amount of the order was increased by 33% from the amount of the last order on the governmental bidding with $4.3 millionin 2013. The company explained that the volume consists...